PTGX Protagonist Therapeutics, Inc. | US74366E1029
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 8.753.421.312 | 6.769.531.905,8 | 5.465.553.294,81 | 4.148.361.004,92 |
| Enterprise Value | 8.215.411.200 | 6.585.595.905,8 | 5.347.486.294,81 | 4.045.397.004,92 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -722,53 | - | - | - |
| Price to Sales | 118,19 | 91,4 | 118,78 | 107,53 |
| Price to Book | 13,34 | 10,33 | 8,89 | 6,43 |
| EV/Revenue | 110,93 | 88,92 | 116,21 | 104,86 |
| EV/EBITDA | -58,26 | - | - | - |